Search

Your search keyword '"Leon-Ferre, R."' showing total 20 results

Search Constraints

Start Over You searched for: Author "Leon-Ferre, R." Remove constraint Author: "Leon-Ferre, R."
20 results on '"Leon-Ferre, R."'

Search Results

1. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

2. 258P Analysis of patients (pts) without an initial triple-negative breast cancer (TNBC) diagnosis (Dx) in the phase III ASCENT study of sacituzumab govitecan (SG) in brain metastases-negative (BMNeg) metastatic TNBC (mTNBC)

3. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

4. Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

5. The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice

6. Tumor-infiltrating lymphocytes in triple-negative breast cancer.

8. Comparison of Transarterial Liver-Directed Therapies (LDT) for Low-Grade Metastatic Neuroendocrine Tumors (mNETs).

9. Clinical Outcomes and Prognostic Factors in Triple-Negative Invasive Lobular Carcinoma of the Breast.

10. Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer.

11. Roles of Notch Signaling in the Tumor Microenvironment.

12. ASCO-Sponsored Oncology Student Interest Groups in the World.

13. A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102.

14. American Society of Clinical Oncology-Sponsored Oncology Student Interest Groups in Latin America.

16. The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.

17. 47-Year-Old Woman With Anemia and Thrombocytopenia.

19. Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide).

20. Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institution.

Catalog

Books, media, physical & digital resources